Colonial Trust Advisors’s Biogen BIIB Stock Holding History

Colonial Trust Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.32K	Hold	20	–	–	﹤0.01%	676
2026 Q1	$3.67K	Hold	20	–	–	﹤0.01%	627
2025 Q4	$3.52K	Hold	20	–	–	﹤0.01%	612
2025 Q3	$2.8K	Hold	20	–	–	﹤0.01%	609
2025 Q2	$2.51K	Buy	+20	New	+$2.49K	﹤0.01%	630
2024 Q1	–	Sell	-4	Closed	-$1.03K	–	1029
2023 Q4	$1.03K	Hold	4	–	–	﹤0.01%	768
2023 Q3	$1.03K	Hold	4	–	–	﹤0.01%	772
2023 Q2	$1.14K	Hold	4	–	–	﹤0.01%	787
2023 Q1	$1.11K	Sell	4 -1	-20%	-$277	﹤0.01%	785
2022 Q4	$1.39K	Buy	+5	New	+$1.41K	﹤0.01%	767

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Colonial Trust Advisors's BIIB Position: Q2 2026 in Review

Colonial Trust Advisors held its Biogen (BIIB) position steady in Q2 2026 at 20 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Colonial Trust Advisors first reported a position in BIIB in Q4 2022 and has held it in 10 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Colonial Trust Advisors held 20 shares of Biogen worth $4.32K as of Q2 2026.
Colonial Trust Advisors left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #676 holding.
Colonial Trust Advisors first reported a position in Biogen in Q4 2022 and has held it in 10 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.